Literature DB >> 12663058

Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus.

A J Graham1, M A Ray, E K Perry, E Jaros, R H Perry, S G Volsen, S Bose, N Evans, J Lindstrom, J A Court.   

Abstract

Neuronal nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels composed of alpha and beta subunits with specific structural, functional and pharmacological properties. In this study the distribution of alpha3, alpha4, alpha7, beta2 and beta4 nAChR subunits in the human hippocampus was investigated using immunohistochemistry. Most pyramidal neurons, pre-alpha cells of the entorhinal cortex and dentate granule cells were immunoreactive for all subunits. Small islands of alpha7 immunoreactive cells were present in the outer presubiculum. alpha4 and beta2, and alpha3, alpha4 and beta2 immunoreactive fibre tracts were present in the stratum radiatum and subiculum, respectively, suggesting nAChRs may play a role in modulating inputs to the hippocampus via Schaffer collaterals and along the perforant pathway. Some astrocytes were immunoreactive for alpha3, alpha7 and beta4 subunits. Immunoreactivity to all subunits was noted in association with blood vessels. These results indicate the involvement of multiple nAChR subtypes in the modulation of both neuronal and non-neuronal functions in the human hippocampus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663058     DOI: 10.1016/s0891-0618(02)00100-x

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  27 in total

1.  Live-cell imaging of single receptor composition using zero-mode waveguide nanostructures.

Authors:  Christopher I Richards; Khai Luong; Rahul Srinivasan; Stephen W Turner; Dennis A Dougherty; Jonas Korlach; Henry A Lester
Journal:  Nano Lett       Date:  2012-06-08       Impact factor: 11.189

Review 2.  α-Conotoxins active at α3-containing nicotinic acetylcholine receptors and their molecular determinants for selective inhibition.

Authors:  Hartmut Cuny; Rilei Yu; Han-Shen Tae; Shiva N Kompella; David J Adams
Journal:  Br J Pharmacol       Date:  2017-06-11       Impact factor: 8.739

3.  The cholinergic system in mild cognitive impairment and Alzheimer's disease: an in vivo MRI and DTI study.

Authors:  Stefan J Teipel; Thomas Meindl; Lea Grinberg; Michel Grothe; Jose L Cantero; Maximilian F Reiser; Hans-Jürgen Möller; Helmut Heinsen; Harald Hampel
Journal:  Hum Brain Mapp       Date:  2010-07-29       Impact factor: 5.038

Review 4.  Nicotinic control of adult-born neuron fate.

Authors:  Nolan R Campbell; Catarina C Fernandes; Danielle John; Adrian F Lozada; Darwin K Berg
Journal:  Biochem Pharmacol       Date:  2011-06-23       Impact factor: 5.858

Review 5.  Physiology of Astroglia.

Authors:  Alexei Verkhratsky; Maiken Nedergaard
Journal:  Physiol Rev       Date:  2018-01-01       Impact factor: 37.312

6.  Trafficking of alpha4* nicotinic receptors revealed by superecliptic phluorin: effects of a beta4 amyotrophic lateral sclerosis-associated mutation and chronic exposure to nicotine.

Authors:  Christopher I Richards; Rahul Srinivasan; Cheng Xiao; Elisha D W Mackey; Julie M Miwa; Henry A Lester
Journal:  J Biol Chem       Date:  2011-07-18       Impact factor: 5.157

Review 7.  Glial cells as therapeutic targets for smoking cessation.

Authors:  Mohit Kumar; Adewale Adeluyi; Erin L Anderson; Jill R Turner
Journal:  Neuropharmacology       Date:  2020-05-24       Impact factor: 5.250

Review 8.  The genetic components of alcohol and nicotine co-addiction: from genes to behavior.

Authors:  Isabel R Schlaepfer; Nicole R Hoft; Marissa A Ehringer
Journal:  Curr Drug Abuse Rev       Date:  2008-06

9.  Characterization of a nicotine-sensitive neuronal population in rat entorhinal cortex.

Authors:  Bin Tu; Zhenglin Gu; Jian-Xin Shen; Patricia W Lamb; Jerrel L Yakel
Journal:  J Neurosci       Date:  2009-08-19       Impact factor: 6.167

10.  Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes.

Authors:  Heather R Bender; Sarah Kane; Mark D Zabel
Journal:  J Vis Exp       Date:  2016-07-23       Impact factor: 1.355

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.